• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Irrevocable Larson Family Investment Trust bought $94,018 worth of shares (87,500 units at $1.07), increasing direct ownership by 3% to 3,557,500 units (SEC Form 4)

    4/15/25 2:02:44 PM ET
    $RMTI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $RMTI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Irrevocable Larson Family Investment Trust

    (Last) (First) (Middle)
    3608 LEXINGTON AVE.

    (Street)
    DALLAS TX 75205

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    ROCKWELL MEDICAL, INC. [ RMTI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    04/10/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 04/10/2025 P 4,000 A $1.0595 3,474,000 D
    Common Stock 04/10/2025 P 4,000 A $1.0799 3,478,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0514 3,480,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0795 3,482,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0793 3,484,000 D
    Common Stock 04/10/2025 P 6,000 A $1.07 3,490,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0698 3,492,000 D
    Common Stock 04/10/2025 P 7,000 A $1.07 3,499,000 D
    Common Stock 04/10/2025 P 10,000 A $1.1009 3,509,000 D
    Common Stock 04/10/2025 P 2,000 A $1.04 3,511,000 D
    Common Stock 04/10/2025 P 2,000 A $1.045 3,513,000 D
    Common Stock 04/10/2025 P 2,000 A $1.049 3,515,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0449 3,517,000 D
    Common Stock 04/10/2025 P 4,000 A $1.055 3,521,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0561 3,523,000 D
    Common Stock 04/10/2025 P 2,000 A $1.065 3,525,000 D
    Common Stock 04/10/2025 P 2,000 A $1.0898 3,527,000 D
    Common Stock 04/11/2025 P 2,000 A $1.0798 3,529,000 D
    Common Stock 04/11/2025 P 1,000 A $1.0888 3,530,000 D
    Common Stock 04/11/2025 P 2,000 A $1.07 3,532,000 D
    Common Stock 04/11/2025 P 2,000 A $1.0749 3,534,000 D
    Common Stock 04/11/2025 P 2,000 A $1.0796 3,536,000 D
    Common Stock 04/11/2025 P 2,000 A $1.08 3,538,000 D
    Common Stock 04/11/2025 P 2,000 A $1.0798 3,540,000 D
    Common Stock 04/11/2025 P 4,000 A $1.09 3,544,000 D
    Common Stock 04/11/2025 P 1,500 A $1.0898 3,545,500 D
    Common Stock 04/11/2025 P 2,000 A $1.0995 3,547,500 D
    Common Stock 04/11/2025 P 2,000 A $1.06 3,549,500 D
    Common Stock 04/11/2025 P 6,000 A $1.08 3,555,500 D
    Common Stock 04/11/2025 P 2,000 A $1.0854 3,557,500 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Grayson Linyard, Attorney in Fact for The Irrevocable Larson Family Investment Trust 04/15/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $RMTI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RMTI

    DatePrice TargetRatingAnalyst
    11/14/2024$5.00Buy
    Rodman & Renshaw
    1/18/2022$5.00 → $3.00Buy
    HC Wainwright & Co.
    9/7/2021$5.50 → $5.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $RMTI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Rodman & Renshaw initiated coverage on Rockwell Medical with a new price target

      Rodman & Renshaw initiated coverage of Rockwell Medical with a rating of Buy and set a new price target of $5.00

      11/14/24 7:56:29 AM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. reiterated coverage on Rockwell Medical with a new price target

      HC Wainwright & Co. reiterated coverage of Rockwell Medical with a rating of Buy and set a new price target of $3.00 from $5.00 previously

      1/18/22 10:00:06 AM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • HC Wainwright & Co. reiterated coverage on Rockwell Medical with a new price target

      HC Wainwright & Co. reiterated coverage of Rockwell Medical with a rating of Buy and set a new price target of $5.00 from $5.50 previously

      9/7/21 6:17:47 AM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $RMTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Irrevocable Larson Family Investment Trust bought $94,018 worth of shares (87,500 units at $1.07), increasing direct ownership by 3% to 3,557,500 units (SEC Form 4)

      4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)

      4/15/25 2:02:44 PM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $RMTI
    SEC Filings

    See more
    • Rockwell Medical Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - ROCKWELL MEDICAL, INC. (0001041024) (Filer)

      5/20/25 4:13:55 PM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Rockwell Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ROCKWELL MEDICAL, INC. (0001041024) (Filer)

      5/12/25 7:21:47 AM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Rockwell Medical Inc.

      10-Q - ROCKWELL MEDICAL, INC. (0001041024) (Filer)

      5/12/25 7:00:44 AM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $RMTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Lau Joan was granted 50,000 shares, increasing direct ownership by 79% to 113,111 units (SEC Form 4)

      4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)

      5/21/25 7:10:30 PM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Cooper John G was granted 50,000 shares, increasing direct ownership by 52% to 145,451 units (SEC Form 4)

      4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)

      5/21/25 7:08:46 PM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Director Nissenson Allen was granted 50,000 shares, increasing direct ownership by 54% to 142,597 units (SEC Form 4)

      4 - ROCKWELL MEDICAL, INC. (0001041024) (Issuer)

      5/21/25 7:07:20 PM ET
      $RMTI
      Biotechnology: Pharmaceutical Preparations
      Health Care